Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The Research at Oxford on Analysis of Motion (ROAM) team at the University of Oxford have supported CURE Ethiopia Children’s Hospital to develop and open a brand new gait laboratory, the first of its kind in the country and the only other active gait lab on the African continent outside of South Africa.

Gait lab doctors with a patient
Image - CURE International

A gait lab uses special motion-capture cameras (the same type of cameras used for making animated movies and computer games) to track a patient’s movement. In the lab, reflective markers are placed all over the patient’s body. The cameras emit light, and when that light is reflected via the reflective markers, the camera follows its movement, thereby recording the joint motion tracking the patient’s movement. In addition to the cameras, the patient also walks on sensitive plates that provide further information. The innovative technology is primarily used for patients with neuromuscular disorders (like cerebral palsy) to analyse their walking and to help determine the ideal treatment for the patient. 

Dr Tim Nunn, Consultant Orthopaedic Surgeon at CURE Ethiopia, said: “Since the gait lab opened, we have been able to assess over 40 patients for severe cerebral palsy conditions. Many of these patients have been discussed with our collaborating team at the Gait Laboratory in Oxford. It has helped us to accurately plan the optimal surgery to achieve the greatest benefit to each patient.”

Image - CURE International Image - CURE International

The gait lab equipment was donated to CURE Ethiopia by three different companies (VICON, AMTI, and NOVEL) coordinated by the ROAM team based at Nuffield Department of Orthopaedics and Rheumatology and Musculoskeletal Sciences at the University of Oxford. Mr. Tim Theologis, a paediatric orthopaedic surgeon and specialist in cerebral palsy from Oxford, has been integral to the project. Dr. Julie Stebbins, an international authority on gait analysis, came to install the equipment and train doctors and physicians in 2019. Dr. Stebbins, who completed her doctorate in bioengineering and biomedical engineering, works in Oxford’s Gait Laboratory at Oxford University Hospitals NHS Foundation Trust.

Dr Stebbins said: “I do the clinical part of the research. We mostly see children who have problems walking, and we measure their gait with the cameras to help find treatment options for them.” 

The Clinical Movement Analysis Society of UK and Ireland recently awarded funding towards this health partnership and Dr Julie Stebbins will visit CURE Ethiopia Children’s Hospital to continue with training and help set up a joint research program. 

Similar stories

Patients and carers invited to join new group helping to shape research and treatment of bones, muscles and joints

Main PPI

Oxford’s newest patient partner group, OPEN ARMS launches today to explore the causes, treatment and care for patients with musculoskeletal conditions. Its first three patient partners explain why they are involved and invite other members of the public to join the team.

NDORMS academics named NIHR Senior Investigators

Main

Congratulations to Professor Jonathan Rees who has been announced as a National Institute of Health Research (NIHR Senior Investigator).

New centre aims to help companies conduct more efficient trials

Botnar Main Trials

A new clinical therapeutics centre has been set up by the University of Oxford to help life sciences companies identify interventions that have the greatest potential to deliver patient benefit, and so bring down the cost of early phase clinical trials.

Cognitive–behavioural therapy consistently improves quality of life

Main Rehabilitation and self-management Research

A meta-review of the available research into cognitive behavioural therapy reveals it consistently improves health-related quality of life across different medical conditions and demographic populations.

Oxford to collaborate with Janssen to map the cellular landscape of immune mediated disorders

Main Research

The University of Oxford has entered into a strategic collaboration with Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson.

Versus Arthritis Foundation Fellowship awarded to Dr Kristina Zec

Awards Main

Dr Kristina Zec has been awarded a Versus Arthritis Foundation Fellowship to investigate the role of products of lipid oxidation produced by synovial macrophages in triggering articular inflammation.